technetium tc 99m dimercaptosuccinic acid has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimoulios, PD; Karkavitsas, NS; Koukouraki, SI; Kouroumalis, EA; Koutroubakis, IE; Velidaki, AA | 1 |
| Karkavitsas, NS; Karmiris, KP; Koukouraki, SI; Kouroumalis, EA; Koutroubakis, IE; Moschandreas, JA; Stathaki, MI | 1 |
2 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Intestines; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid | 2003 |
Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Inflammatory Bowel Diseases; Leukocytes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Exametazime | 2008 |